Abingdon, UK - OBN, the membership organisation supporting the UK’s innovative life sciences companies is pleased to announce today that Venner Shipley, a leading firm of European patent & trade mark attorneys and IP lawyers, has become OBN’s exclusive patent and trade mark attorney sponsor.

Through their sponsorship of OBN’s activities, thirteen best-in-class companies are now actively supporting the UK life sciences sector. Venner Shipley joins Corporate Patron, Ipsen and Corporate Sponsors, MEPC Milton Park, Fieldfisher, James Cowper Kreston LLP, World Courier, Arthur J Gallagher, PCI, EY, Penningtons Manches LLP, Horton International, Fisher Scientific, and Citigate Dewe Rogerson.

Dr John Harris, CEO of OBN, said: “We’re thrilled to be working with Venner Shipley and excited that they have come on board as a Corporate Sponsor. Venner Shipley's support is a ringing endorsement of the work that OBN does in nurturing and developing the innovative life sciences sector. Companies operating in this space need quality, responsiveness, value for money, and flexibility – all qualities and attributes encapsulated by Venner Shipley’s approach and culture. We look forward to working closely with the team at Venner Shipley over the coming months and years”.

Venner Shipley, through its patent and trade mark filing, advisory and legal capabilities, will support OBN in meeting the aims of its initiative: to provide networking, partnering, group purchasing services, investor introductions, cluster consultancy and better communication across the life sciences industry.

Dr Anton Hutter, Partner in Venner Shipley’s Chemical & Life Sciences department, said: “We are delighted to have the opportunity to sponsor OBN, and to work more closely with the OBN team. We are especially looking forward to helping its members leverage their intellectual property to maximise its value, and have a number of initiatives that we plan to roll out in the coming months. We’re a highly dynamic firm with significant experience of working with clients of all sizes and always work to understand their needs and adapt our approach as required.  Our experience in nurturing our clients in the life sciences sector aligns well with what OBN sets out to achieve.  We are looking forward to meeting members at upcoming OBN events.”